PHARMACOKINETICS OF HEPARIN .5. INVIVO AND INVITRO FACTORS AFFECTING THE RELATIONSHIP BETWEEN CONCENTRATION AND ANTICOAGULANT EFFECT OF HEPARIN IN RAT PLASMA

被引:3
作者
WHITFIELD, LR [1 ]
LEVY, G [1 ]
机构
[1] SUNY BUFFALO, SCH PHARM, DEPT PHARMACEUT, BUFFALO, NY 14260 USA
关键词
D O I
10.1002/jps.2600721008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1141 / 1146
页数:6
相关论文
共 15 条
[1]  
BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P237
[2]  
BJORNSSON TD, 1980, ANN NY ACAD SCI, V370, P656
[3]   HEPARIN KINETICS - VARIABLES RELATED TO DISPOSITION AND DOSAGE [J].
CIPOLLE, RJ ;
SEIFERT, RD ;
NEILAN, BA ;
ZASKE, DE ;
HAUS, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :387-393
[4]   A SIMPLIFIED METHOD FOR MONITORING HEPARIN-THERAPY AT THE BEDSIDE - THE ACTIVATED WHOLE-BLOOD CLOTTING TIME [J].
FORMAN, WB ;
BAYER, G .
AMERICAN JOURNAL OF HEMATOLOGY, 1981, 11 (03) :277-281
[5]   HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].
HIRSH, J ;
VANAKEN, WG ;
GALLUS, AS ;
DOLLERY, CT ;
CADE, JF ;
YUNG, WL .
CIRCULATION, 1976, 53 (04) :691-695
[6]  
JAQUES L B, 1973, Thrombosis Research, V3, P295, DOI 10.1016/0049-3848(73)90055-8
[7]  
JAQUES LB, 1973, THROMB DIATH HAEMOST, P171
[8]   HETEROGENEITY OF HEPARIN - CHARACTERIZATION OF 100 COMPONENTS WITH DIFFERENT ANTICOAGULANT ACTIVITIES BY A COMBINATION OF ELECTROPHORETIC AND AFFINITY-CHROMATOGRAPHY METHODS [J].
NADER, HB ;
TAKAHASHI, HK ;
GUIMARAES, JA ;
DIETRICH, CP ;
BIANCHINI, P ;
OZIMA, B .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1981, 3 (06) :356-360
[9]  
PROCTOR RR, 1961, AM J CLIN PATHOL, V36, P212
[10]  
SOKAL RR, 1969, BIOMETRY, P450